GlaxoSmithKline outlined a plan to split the company into two entities over the next two years.
Takeda Pharmaceutical has entered into an agreement to transfer its Japan Consumer Healthcare Business Unit to Takeda Consumer Healthcare.
In Tuesday’s conference call, Indianapolis-based Eli Lilly & Co. (LLY) indicated it is splitting its animal health drugs manufacturing facilities from its human drug manufacturing plants. Bloomberg Business speculates that this is a move that might eventually lead to spinning off the division. For the moment, however, company representatives insist that the rationale is […]